ZAC1 target genes and pituitary tumorigenesis

被引：44

作者：

Theodoropoulou, Marily ^{[1
]}

Stalla, Guenter K. ^{[1
]}

Spengler, Dietmar ^{[2
]}

机构：

[1] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany

[2] Max Planck Inst Psychiat, Dept Mol Neuroendocrinol, D-80804 Munich, Germany

来源：

MOLECULAR AND CELLULAR ENDOCRINOLOGY | 2010年 / 326卷 / 1-2期

关键词：

ZAC1; Pituitary; Target genes; Biomarker; Somatostatin; ZINC-FINGER PROTEIN; NEONATAL DIABETES-MELLITUS; BECKWITH-WIEDEMANN-SYNDROME; DEPENDENT KINASE INHIBITOR; ACTIVATED-RECEPTOR-GAMMA; DNA-BINDING; SOMATOSTATIN ANALOG; PPAR-GAMMA; PHOSPHATIDYLINOSITOL; 3-KINASE; TRANSCRIPTIONAL COACTIVATOR;

D O I：

10.1016/j.mce.2010.01.033

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The zinc-finger protein Zac1 has a role as transcription factor and coregulator and plays an important role in pituitary development, maturation and tumorigenesis. Zac1 target genes control cell proliferation and hormone synthesis. While Zac1 is highly expressed in all hormone-producing cells of the pituitary, loss of expression frequently occurs in pituitary adenomas, in particular in non-functioning tumors. Zac1 lies downstream to the mitogenic MAPK and survival PI3K pathways. In turn, inhibition of the PI3K pathway by therapeutic agents, like somatostatin analogs up-regulate Zac1 expression. In fact Zac1 is an essential mediator of the antiproliferative effects of this treatment and correlates to successful outcome in acromegalic patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：60 / 65

页数：6

共 52 条

[1] Abdollahi A, 1997, CANCER RES, V57, P2029
[2] LOT1 (ZAC1/PLAGL1) and its family members: Mechanisms and functions
Abdollahi, Abbas
[J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 210 (01) : 16 - 25
[3] A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus
Arima, T
Drewell, RA
Arney, KL
Inoue, J
Makita, Y
Hata, A
Oshimura, M
Wake, N
Surani, MA
[J]. HUMAN MOLECULAR GENETICS, 2001, 10 (14) : 1475 - 1483
[4] ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome
Arima, T
Kamikihara, T
Hayashida, T
Kato, K
Inoue, T
Shirayoshi, Y
Oshimura, M
Soejima, H
Mukai, T
Wake, N
[J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (08) : 2650 - 2660
[5] Peroxisome proliferator-activated receptor γ is a Zac target gene mediating Zac antiproliferation
Barz, Thomas
Hoffmann, Anke
Panhuysen, Markus
Spengler, Dietmar
[J]. CANCER RESEARCH, 2006, 66 (24) : 11975 - 11982
[6] The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas
Basyuk, E
Coulon, V
Le Digarcher, A
Coisy-Quivy, M
Moles, JP
Gandarillas, A
Journot, L
[J]. MOLECULAR CANCER RESEARCH, 2005, 3 (09) : 483 - 492
[7] The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
Bhayana, S
Booth, GL
Asa, SL
Kovacs, K
Ezzat, S
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) : 6290 - 6295
[8] Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors
Bilanges, B
Varrault, A
Basyuk, E
Rodriguez, C
Mazumdar, A
Pantaloni, C
Bockaert, J
Theillet, C
Spengler, D
Journot, L
[J]. ONCOGENE, 1999, 18 (27) : 3979 - 3988
[9] Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities
Bilanges, B
Varrault, A
Mazumdar, A
Pantaloni, C
Hoffmann, A
Bockaert, J
Spengler, D
Journot, L
[J]. ONCOGENE, 2001, 20 (10) : 1246 - 1253
[10] Distinct Developmental Roles of Cell Cycle Inhibitors p57Kip2 and p27Kip1 Distinguish Pituitary Progenitor Cell Cycle Exit from Cell Cycle Reentry of Differentiated Cells
Bilodeau, Steve
Roussel-Gervais, Audrey
Drouin, Jacques
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (07) : 1895 - 1908

← 1 2 3 4 5 6 →